InvestorQ : What is the deal between Cipla and Boehringer in the pharma space?
Aditi Sharma made post

What is the deal between Cipla and Boehringer in the pharma space?

Answer
user profile image
Aashna Tripathi answered.
4 months ago


Cipla and Boehringer Ingelheim (India) announced a partnership to co-market three new oral anti-diabetic drugs. Currently, India is home to 7.7 crore diabetic adults between 20-79 age group. Diabetes has remained a focus area for Cipla and the strategic tie-up with Boehringer Ingelheim should be positive for the stock market in the long run.

The generic Oboravo is approved for glucose-control in patients with type-2 diabetes. It is also approved for reducing the risk of cardiovascular death, in patients with type-2 diabetes as well as having cardiovascular disease. This becomes important in a country like India as diabetes has been a silent killer for a long time in India.